OMNISCAN 0,5 mmol/ml, solution injectable en seringue pré-remplie Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

omniscan 0,5 mmol/ml, solution injectable en seringue pré-remplie

ge healthcare sas - gadodiamide 287 mg - solution - 287 mg - pour 1 ml > gadodiamide 287 mg - produit de contraste pour imagerie par résonance - produits de contraste pour imagerie par resonance magnetique (v-divers) - code atc : v08ca03ce médicament est à usage diagnostique uniquement.ce médicament est un produit de contraste radiologique (propriétés opacifiantes), il vous a été prescrit en vue d’un examen par irm (imagerie par résonance magnétique).

Omniscan 0.5 mmol/ml solution for injection Malta - engelsk - Medicines Authority

omniscan 0.5 mmol/ml solution for injection

ge healthcare as nycoveien 1, no-0485 oslo, norway - gadodiamide - solution for injection - gadodiamide - contrast media

PROHANCE gadoteridol 2793mg/10mL injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

prohance gadoteridol 2793mg/10ml injection vial

bracco pty ltd - gadoteridol, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; calteridol calcium; trometamol; sodium hydroxide; water for injections - do not freeze (syringe only). prohance is indicated for use in adults and children from 2 years of age for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity. prohance can also be used for whole body mri.

PROHANCE gadoteridol 4189.5mg/15mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

prohance gadoteridol 4189.5mg/15ml injection syringe

bracco pty ltd - gadoteridol, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; trometamol; calteridol calcium - do not freeze (syringe only). prohance is indicated for use in adults and children from 2 years of ge for enhancement of magnetic images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity. prohance can also be used for whole body mri.

PROHANCE gadoteridol 2793mg/10mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

prohance gadoteridol 2793mg/10ml injection syringe

bracco pty ltd - gadoteridol, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; calteridol calcium; trometamol; sodium hydroxide; water for injections - do not freeze (syringe only). prohance is indicated for use in adults and children from 2 years of age for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity. prohance can also be used for whole body mri.

PROHANCE gadoteridol 5586mg/20mL injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

prohance gadoteridol 5586mg/20ml injection vial

bracco pty ltd - gadoteridol, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; calteridol calcium; trometamol; hydrochloric acid; water for injections - do not freeze (syringe only). prohance is indicated for use in adults and children from 2 years ofage for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity. prohance can also be used for whole body mri.

PROHANCE gadoteridol 4189.5mg/15mL injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

prohance gadoteridol 4189.5mg/15ml injection vial

bracco pty ltd - gadoteridol, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: trometamol; sodium hydroxide; calteridol calcium; water for injections; hydrochloric acid - do not freeze (syringe only). prohance is indicated for use in adults and children from 2 yaers of age for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity. prohance can also be used for whole body mri.

Omniscan 0,5 mmol/ml sol. inj. i.v. flac. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

omniscan 0,5 mmol/ml sol. inj. i.v. flac.

ge healthcare bv-srl - gadodiamide 287 mg/ml - solution injectable - gadodiamide

Omniscan 0,5 mmol/ml sol. inj. i.v. flac. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

omniscan 0,5 mmol/ml sol. inj. i.v. flac.

ge healthcare bv-srl - gadodiamide 287 mg/ml - solution injectable - gadodiamide

Omniscan 0,5 mmol/ml sol. inj. i.v. ser. préremplie Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

omniscan 0,5 mmol/ml sol. inj. i.v. ser. préremplie

ge healthcare bv-srl - gadodiamide 287 mg/ml - solution injectable - gadodiamide